TrianglePUBLICATIONS · 20564162
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2010 Aug 15
- First author
- Cianfrocca M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Cianfrocca M
- type
- Author
- name
- Lee S
- type
- Author
- name
- Von Roenn J
- type
- Author
- name
- Tulpule A
- type
- Author
- name
- Dezube BJ
- type
- Author
- name
- Aboulafia DM
- type
- Author
- name
- Ambinder RF
- type
- Author
- name
- Lee JY
- type
- Author
- name
- Krown SE
- type
- Author
- name
- Sparano JA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cianfrocca M
- type
- Author
- name
- Lee S
- type
- Author
- name
- Von Roenn J
- type
- Author
- name
- Tulpule A
- type
- Author
- name
- Dezube BJ
- type
- Author
- name
- Aboulafia DM
- type
- Author
- name
- Ambinder RF
- type
- Author
- name
- Lee JY
- type
- Author
- name
- Krown SE
- type
- Author
- name
- Sparano JA
- type
- Author
- bibliography ids
- nci-bib-1b9d394565e0add0efbb3951
- book metadata
- content sha256
- 4a7813fde91250c3edd6517b946777065d4820ee1ff164d2a10d5f174f9a8175
- document type
- citation
- dois
- 10.1002/cncr.25362
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20564162
- immutable id
- pubmed:20564162@4a7813fde91250c3edd6517b946777065d4820ee1ff164d2a10d5f174f9a8175
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 16
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 3969-77
- volume
- 116
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 20564162
- provenance
- batch id
- bce21fa556c206e375c2
- provider
- NCBI PubMed ESummary
- record sha256
- 3ef6e7824eeab69737dc09249462c30fda0762cb1a4d097659f46686f377e1de
- response sha256
- 280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
- retrieved at
- 2026-09-09T23:46:33.526275+00:00
- publication date
- display
- 2010 Aug 15
- precision
- day
- year
- 2010
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
Preserved source evidence · Not medical advice